Dienogest
- Generic Name
- Dienogest
- Brand Names
- Natazia, Visanne
- Drug Type
- Small Molecule
- Chemical Formula
- C20H25NO2
- CAS Number
- 65928-58-7
- Unique Ingredient Identifier
- 46M3EV8HHE
- Background
Dienogest is an orally-active semisynthetic progestogen which also possesses the properties of 17α-hydroxyprogesterone. It is a derivative of 19-nortestosterone and has antiandrogenic properties. It is primarily used as a contraceptive in combination with ethinylestradiol, or in other combination form pills approved in United States and Europe however it is ...
- Indication
Indicated for use as the treatment of endometriosis alone and as a contraceptive in combination with ethinylestradiol.
- Associated Conditions
- Hypermenorrhea, Pain
- Associated Therapies
- Contraception, Oral Contraceptives
Endometriosis drug Visanne to be PBS-listed in 30-year first
Endometriosis sufferers gain access to new affordable treatment after 30 years.
Endometriosis drug Visanne to be PBS listed in 30-year first
Endometriosis sufferers will have access to the new affordable treatment Visanne under the PBS, marking the first time in 30 years. The drug, costing $380 to $800 annually, suppresses abnormal tissue growth and is crucial for managing symptoms, which can significantly impact quality of life.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath